Executive Briefing on ORAL ONCOLYTICS
Jan 30, 2015
The 16 page whitepaper includes:
Understand the realities and trade-offs for oral therapeutics
Strategic perspectives and pharma case examples
Learn about the next frontier of new agents
Please subscribe to view the analysis report